Clinical Trial Update: Immunosuppression After Repeat Keratoplasty [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for repeat keratoplasty examining immunosuppression, spanning Phase 2 and Phase 3, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratopathy

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Keratopathy | Phase 2, Phase 3 | Status: UNKNOWN